| Page 1963 | Kisaco Research
9.3 Rising Star Travel Grant
 

Manish Bharti

Sales Leader
UiPath

Manish Bharti is Sales Leader at UiPath. He brings in 21 years of global techno- businesses experiences with his current focus on working with large enterprises on their transformation journey involving RPA, Cognitive & AI.  

In his current role as a Revenue Officer, he is responsible for building top line revenues and drive customer acquisitions and delight. Manish is an alumnus of IIM-B & HBS

Manish Bharti

Sales Leader
UiPath

Manish Bharti

Sales Leader
UiPath

Manish Bharti is Sales Leader at UiPath. He brings in 21 years of global techno- businesses experiences with his current focus on working with large enterprises on their transformation journey involving RPA, Cognitive & AI.  

In his current role as a Revenue Officer, he is responsible for building top line revenues and drive customer acquisitions and delight. Manish is an alumnus of IIM-B & HBS

 

Paulo Refinetti

Researcher
Ecole Polytechnique Federale Lausanne

Paulo Refinetti

Researcher
Ecole Polytechnique Federale Lausanne

Paulo Refinetti

Researcher
Ecole Polytechnique Federale Lausanne
North American Microbiome Congress Poster Submission Form
 

Arvind Kasturirangan

VP & India Business Head
Automation Anywhere

Arvind Kasturirangan

VP & India Business Head
Automation Anywhere

Arvind Kasturirangan

VP & India Business Head
Automation Anywhere
 

Balaji Hariharan

Director India & Asia-Pacific
Softomotive

Balaji Hariharan

Director India & Asia-Pacific
Softomotive

Balaji Hariharan

Director India & Asia-Pacific
Softomotive
 

Rajesh Krishnaswamy

VP, Professional Services, Asia
Automation Anywhere

Rajesh Krishnaswamy

VP, Professional Services, Asia
Automation Anywhere

Rajesh Krishnaswamy

VP, Professional Services, Asia
Automation Anywhere
 

Vishal Dogra

Key Accounts Manager
Automation Anywhere

Vishal Dogra

Key Accounts Manager
Automation Anywhere

Vishal Dogra

Key Accounts Manager
Automation Anywhere
 

Mallory Embree

CO-founder and Chief Scientific Officer
Ascus

Mallory’s entire career has focused on researching and developing new methodologies to study both natural and synthetic microbial communities. Her area of expertise centers around the integration of bioinformatics with multiple omics datasets, physiological measurements, and metabolic modeling to examine microbial communities from a species-centric perspective.

Mallory Embree

CO-founder and Chief Scientific Officer
Ascus

Mallory Embree

CO-founder and Chief Scientific Officer
Ascus

Mallory’s entire career has focused on researching and developing new methodologies to study both natural and synthetic microbial communities. Her area of expertise centers around the integration of bioinformatics with multiple omics datasets, physiological measurements, and metabolic modeling to examine microbial communities from a species-centric perspective. She has studied microbial communities from a diverse range of environments beyond livestock, including liver-disease mouse models, human skin microbiomes, brewery wastewater digesters, slow-growing methanogenic alkane-degrading enrichments, and low-biomass deep subsurface sediments from the ocean gyres.
Together with her co-founder, Mike Seely, Mallory founded Ascus Biosciences in 2015 to discover, develop, and commercialize first-in-class endomicrobial products for the animal health & nutrition industries. Outside of her passion for microbial communities and microbial product development, Mallory spends a lot of her free time working on airplanes, hot-air balloons and doing yoga. Mallory received her Ph.D. in Bioengineering from the University of California, San Diego.

About Ascus
Ascus Biosciences, based in San Diego, CA, is focused on discovering, developing, and commercializing first-in-class endomicrobial products for the animal health and nutrition industries. Founded in 2015, Ascus is pioneering the emerging science of endomicrobial ecology to illuminate microbial communities within animals, and the role they play in overall health and performance. Ascus has a broad pipeline of all-natural, endomicrobial products in development across livestock and companion animals. Galaxis is their lead product and could launch as early as 2018 in the dairy market.

 

Dr Thomas Kuri

Scientific Director
Zymo Research Europe GmbH

Dr Thomas Kuri

Scientific Director
Zymo Research Europe GmbH

Dr Thomas Kuri

Scientific Director
Zymo Research Europe GmbH